OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,000 | -41.1% | 20,138 | -2.9% | 0.00% | – |
| Q2 2023 | $107,000 | -4.5% | 20,738 | -1.6% | 0.00% | – |
| Q1 2023 | $112,000 | +89.8% | 21,068 | 0.0% | 0.00% | – |
| Q4 2022 | $59,000 | -34.4% | 21,068 | -3.2% | 0.00% | – |
| Q3 2022 | $90,000 | +3.4% | 21,768 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -19.4% | 21,768 | 0.0% | 0.00% | – |
| Q1 2022 | $108,000 | -19.4% | 21,768 | +13.0% | 0.00% | – |
| Q4 2021 | $134,000 | +4.7% | 19,268 | +50.9% | 0.00% | – |
| Q3 2021 | $128,000 | -12.3% | 12,768 | +24.3% | 0.00% | – |
| Q2 2021 | $146,000 | -21.1% | 10,268 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $185,000 | -29.1% | 11,284 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $261,000 | -67.0% | 12,660 | -86.8% | 0.00% | -75.0% |
| Q2 2020 | $790,000 | – | 95,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |